What are hormonal contraceptives?

Hormonal contraceptives are medications used to prevent pregnancy by regulating hormones. They include pills, patches, injections, implants, and intrauterine devices (IUDs) that release hormones such as estrogen and progestin.

How big is the Hormonal Contraceptives Market?

The global Hormonal Contraceptives Market size was estimated at USD 17.3 Billion in 2023 and is expected to reach USD 24.6 Billion in 2033.

What is the Hormonal Contraceptives Market growth?

The global Hormonal Contraceptives Market is expected to grow at a compound annual growth rate of 4.1%. From 2024 To 2033

Who are the key companies/players in the Hormonal Contraceptives Market?

Some of the key players in the Hormonal Contraceptives Markets are Abbvie, Inc.; Afaxys, Inc.; Teva Pharmaceuticals Industries Ltd; Merck & Co. Inc.; The Female Health Company; Bayer AG, Pfizer, Inc.; Mylan N.V.; Johnson & Johnson; Ansell LTD; Mayer Laboratories; Church & Dwight, Co, Inc., and others

How do hormonal contraceptives work?

Hormonal contraceptives prevent ovulation, thicken cervical mucus to block sperm, and thin the uterine lining to prevent implantation. These mechanisms collectively reduce the likelihood of pregnancy.

What are the benefits of using hormonal contraceptives?

Benefits include effective pregnancy prevention, regulation of menstrual cycles, reduced menstrual cramps, and decreased risk of ovarian cysts and certain cancers. They can also manage symptoms of conditions like polycystic ovary syndrome (PCOS).

What factors are driving the growth of the hormonal contraceptives market?

Factors driving growth include increased awareness of family planning, advancements in contraceptive technologies, a growing focus on women's health, and supportive government policies promoting contraceptive use.

What challenges does the hormonal contraceptives market face?

Challenges include potential side effects, cultural and religious opposition, limited access in some regions, and the need for continuous research and development to improve efficacy and reduce adverse effects.

Global Hormonal Contraceptives Market By Product Type (Emergency Contraceptive Pills, Oral Contraceptive Pills, Injectable Birth Control), By Hormones Type (Combined Hormonal Contraceptive, and Progestin - Only Contraceptive), By User's Age Type (15-24 Years, 25-34 Years, 35-44 Years), By End User Type (Hospitals, Households, Gynecology Centers), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast; 2023-2032

Published date: July 2024
Report ID: 95696
Number of Pages: 284
Format:

- AbbVie Inc. Company Profile
- Afaxys, Inc.
- Bayer AG Company Profile
- Pfizer, Inc
- Johnson & Johnson
- Janssen Pharmaceuticals Inc.
- Lupin Pharmaceuticals Inc.
- Pregna International Ltd.
- The Female Health Company
- Teva Pharmaceutical Industries Limited
- Mylan N.V.
- Ansell Ltd. Company Profile
- Merck & Co. Inc.
- Church & Dwight, Co, Inc.
- Mayer Laboratories
- Novartis AG Company Profile
- Agile Therapeutics
- Other Key Players
Settings

Related Reports

Our Clients

Inquiry Before Buying

Report ID 95696
Published Date July 2024
Rating
- ★★★★★
  
  ★★★★★
- (75)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)